Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · ArcBest (ARCB)

ArcBest amends and restates $250 million revolving credit facility, maturing 2030

Neutral Impact 3 of 5 financing Written later

ArcBest entered a Fifth Amended and Restated Credit Agreement on November 25, 2025, refinancing its revolving credit facility with U.S. Bank National Association as administrative agent. The facility's maturity is extended to November 25, 2030, and the letter of credit sublimit rises from $20 million to $50 million. The filing does not state any borrowings outstanding, so the impact on shareholders is mainly the terms under which the company can borrow.

Key points

  • Maximum credit amount of $250 million, with a five-year term ending November 25, 2030
  • Swing line sublimit of $40 million and letter of credit sublimit increased from $20 million to $50 million
  • Accordion feature allows requests for up to an additional $125 million, subject to conditions
  • Borrowing spreads range from 0.125% to 1.00% over the Alternate Base Rate or 1.125% to 2.00% over Adjusted Term SOFR, based on leverage

The filing

CompanyArcBest (ARCB)
Form8-K, current report
Filed with the SECNov 26, 2025, 6:01 AM ET
Accession number0001104659-25-116139

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 26, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.